Cardiovascular disease (CVD), the leading cause of death in developed countries and dyslipidemia, is a major risk factor for CVD. We previously identified a cluster of quantitative trait loci (QTL) on baboon chromosome 11 for multiple related quantitative traits for serum low-density lipoprotein cholesterol (LDL-C). Here we report differentially regulated hepatic genes encoding an LDL-C QTL that influences LDL-C levels in baboons. We performed hepatic whole genome expression profiling for LDL-C discordant baboons fed a high-cholesterol, high-fat (HCHF) diet for 7 weeks. We detected expression of 117 genes within the QTL 2-LOD-support interval. Three genes were differentially expressed in low LDL-C responders and 8 in high LDL-C responders in response to a HCHF diet. Seven genes (ACVR1B, CALCOCO1, DGKA, ERBB3, KRT73, MYL6B, TENC1) showed discordant expression between low and high LDL-C responders. To prioritize candidate genes, we integrated miRNA and mRNA expression profiles using network tools and found that four candidates (ACVR1B, DGKA, ERBB3, TENC1) were miRNA targets and the miRNAs were inversely expressed to the target genes.
INTRODUCTION
induced and maintained with isoflurane (1-2%). Blood pressure was measured by automated arm cuff (Coulin), and oxygen saturation, heart and respiration rates were monitored by pulse oximetry. During post biopsy recovery, analgesia was provided in the form of Stadol, 0.15 mg/kg, bid, for 3 days and ampicillin, 25 mg/day, for 10 days. Liver biopsies were quick frozen in liquid nitrogen at the time of collection and stored at -80 o C for later RNA extractions.
All animal surgical procedures were conducted by staff veterinarians at SNPRC in conformity with the 
RNA Isolation from Liver
RNA was isolated from liver tissue using Trizol Reagent (Ambion Inc., Austin, TX) according to the manufacturer's instructions. Approximately 20-30 mg of frozen liver was cut on an aluminum plate on dry ice and homogenized in 1ml Trizol Reagent using a PowerGen 125 Homogenizer (Thermal Scientific, Pittsburgh, PA). Genomic DNA in the sample was sheared by passing the homogenate three times through a 22-gauge needle attached to a 1ml syringe. The homogenized samples were incubated for 5 min at 25 o C. Chloroform (200 μl) was added to resulting lysate, shaken vigorously by hand for 15 s and incubated at room temperature for 3 min. Samples were then centrifuged at 14,000 x g for 10 min
at 4 o C. The upper aqueous phase containing RNA was carefully aspirated and transferred to a cleaning column from an RNeasy MinElute Kit (Qiagen Valencia, CA). RNA was precipitated and stored at −80 o C.
Validation of gene expression for targeted genes
mRNA expression levels of candidate genes were quantified using Taqman probes (Applied Biosystems, AB). We optimized cDNA concentrations for QRT-PCR by titrating a range of RNA concentrations from a pool of representative RNAs for the low and high LDL-C responder baboons.
After optimization, individual cDNAs were synthesized and expression determined by QRT-PCR using AB7900 Real-Time PCR System. We quantified mRNA according to manufacturer's instructions. In brief, total RNA (200ng) was reverse transcribed in a 10-μl reaction using a SuperScript III Kit (Invitrogen). For real-time PCR, target cDNA, gene specific primers and 1 X TaqMan Universal PCR master mix (AB) were employed. 18S rRNA (Hs99999901_s1) was quantified as an endogenous control. Expression abundance was quantified for v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 also known as epidermal growth factor receptor 3 (ERBB3; AB catalog number Hs00951456_g1), calcium binding and coiled-coil domain 1 (CALCOCO1; Hs01548317_m1), and tensin-like C1 domain containing phosphatase (TENC1; Hs00539259_g1). All samples were assayed in triplicate. The relative expression of each gene was determined using the formula ΔΔCt by subtracting the ΔCt of the calibrator (optimized pool of RNA from low and high LDL-C) from ΔCt of target gene.
Fold difference was calculated using the expression 2 -ΔΔCt .
Protein quantification
Cell lysate was prepared by homogenizing 1-3 mg of frozen liver tissue in a Biomasher microhomogenizer (ISC Bio Express, UT) in ice-cold RIPA lysis buffer (12.5 mM Tris-HCl/ pH 7.6, 0.5% Np-40, 0.5% sodium deoxycholic acid, 0.1% sodium dodecylsulfate (SDS), 75 mM sodium chloride).
RIPA buffer contained 1 X Halt protease inhibitor cocktail (Thermal Scientific). Cell debris was removed by centrifugation at 15, 000 x g for 20 sec at 4 o C. Supernatants were assayed for total protein concentration by Bio-Rad protein assay and diluted to a working concentration (3ug/ul) using the lysing buffer.
Protein analysis was performed using SDS-PAGE and Western blot. After boiling for 5 min at 95 o C in 1X SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% SDS, 0.01% bromophenol blue) containing 5% β-mercaptoethanol, the lysates (18ug) were run in 10% polyacrylamide gel under reducing conditions and then transferred onto PVDF membrane (Bio-Rad Laboratories, CA) overnight at 4 o C. The membrane was washed with double distilled water 3 times for 5 min each, and then incubated with a StartingBlock blocking buffer (Thermal Scientific) for 20 min at room temperature.
Subsequently, the membrane was incubated with TENC1, ERBB3, DGKA, ACVR1B primary antibodies, or, β-Actin (control) in blocking solution overnight at 4 o C. After washing 3 times with 1X
TBST buffer (20mM Tris, 500mM NaCl/pH 7.5, 0.05% Tween 20) for 10 min each, the membrane was incubated with goat anti-rabbit secondary antibody for 90 min at room temperature. and identify miRNA targets with expression profiles that are negatively correlated with miRNA expression.
RESULTS

LDL-C serum concentrations for the baboon panel
The mean ± SD LDL-C serum concentrations for the low and high LDL-C responders, before and at the end of the 7-week diet challenge, are shown in Table 1 .
Whole Genome Expression Profiling
For low LDL responders, we detected 9,904 genes and found 83 genes up-regulated and 87 down- Table I ). For high LDL-C responders, we detected 9,992 genes and 96 genes were up-regulated and 117 down-regulated in response to the HCHF diet challenge. Pathway analysis revealed that an equal number of biological pathways (n = 16) were up-regulated or down-regulated in response to the HCHF diet challenge. Up-regulated pathways included: Basal transcription factors, bile acid biosynthesis, notch signaling and glycerolipid metabolism. Down-regulated pathways included: Ribosome, glycolysis/gluconeogenesis and urea cycle and metabolism of amino groups (Supplemental Table II) .
Overall, a greater number of genes (N = 213) were differentially expressed in the livers of high LDL-C responders in response to the HCHF diet challenge compared to livers of low LDL-C responders (N=170) (X
Expression of Genes in the QTL 2-LOD Support Interval
We identified candidate genes encoding variation in LDL-C concentration QTL in baboons. The 2-LODsupport interval of the QTL includes 229 genes. Among these genes, 117 passed quality filter for expression in our LDL-C discordant baboons. Three genes were differentially expressed (p ≤ 0.05) in response to HCHF diet in low LDL-C baboons while eight genes were differentially expressed in response to HCHF diet in high LDL-C responders (Table 2) . Two genes keratin 80 (KRT80), glutaminase 2 (GLS2) were up-regulated in both low and high LDL-C responders; while seven including activin A receptor, type IB (ACVR1B), diacylglycerol kinase alpha (DGKA), keratin 73 (KRT73), myosin light chain 6B (MYL6B), TENC1, CALCOCO1 and ERBB3 showed a differential response to the HCHF diet between low and high LDL-C responders ( Table 2) .
miRNA-gene expression of candidates
To further prioritize on the seven discordant candidate genes, we identified those targeted by at least one miRNA that exhibited differential response to HCHF in low and high LDL-C baboons (19) and showed inverse expression between the miRNA and targeted gene. Differential expression of these genes and the corresponding targeting-miRNAs are shown in Table 3 . For example, TENC1 which is up-regulated in response to HCHF diet in low LDL-C baboon livers is targeted by miR-34 family that is down-regulated in response to the diet challenge. A miRNA-mRNA interaction module for high LDL-C baboon responders is shown in Figure 2 . ERBB3 and ACVR1B, which are up-regulated in response to HCHF diet in high LDL-C baboon livers are targeted by two or more miRNAs that are down-regulated in response to the diet challenge. miR-17 family, which is down-regulated by 410-fold in response to the diet challenge, is predicted to target both ACVR1B and ERBB3..
Validation of gene expression -QRT-PCR
Gene array expression was confirmed by QRT-PCR ( Figure 3 ). TENC1 was up-regulated in low LDL-C responders in response to the HCHF diet (p < 0.05) with no change in high LDL-C responders.
CALCOCO1 and ERBB3 were up-regulated in high LDL-C responders (p < 0.05) with no change in low LDL-C responders.
Quantification of protein expression
TENC1 protein expression was up-regulated in low LDL-C responders in response to the HCHF diet but not in high LDL-C responders (Figure 4 ). Baboon ACVR1B, DGKA, CALCOCO1 and ERBB3 proteins
were not detected using commercially available antibodies.
Candidate genes and pathways
ERBB3, DGKA, TENC1 and ACVR1B are involved in AKT1/GSK3β and ACVR/SMAD pathways respectively ( Figure 5 ).
DISCUSSION
Previously we reported a cluster of multiple LDL-C-related QTLs on baboon chr 11 including one QTL influencing variation in LDL-C serum concentration (LOD = 12) (13). In the human genome, 229 genes are encoded within the homologous baboon 2-LOD-support interval for the LDL-C concentration QTL (UCSC Genome Browser, Feb. 2009, GRCH37/hg19). In this study, we used hepatic whole genome expression profiling of half-sib baboons discordant for serum LDL-C and genotypes of markers within baboon chr 11 LDL-C concentration QTL to discover candidate genes encoding the LDL-C serum concentration QTL. This approach augmented detection of genes influencing LDL-C variation by maximizing genetic differences in the QTL interval while minimizing genetic background.
We identified 9,945 genes expressed in the baboon liver transcriptome. Among these genes, 146 were differentially expressed in low LDL-C baboons in response to the HCHF diet and 213 were differentially expressed in high LDL-C baboons in response to the HCHF diet. The significant difference in number of diet responsive genes in low LDL-C responders compared with high LDL-C responders suggests that different molecular mechanisms underlie the HCHF response between the two phenotypes.
We hypothesized that the candidate gene(s) encoding the LDL-C concentration QTL would be discordantly expressed between low and high LDL-C responders. Within the 2-LOD support interval of the LDL-C QTL, 117 of the 229 genes were expressed of which nine were differentially expressed in response to HCHF diet in at least one of the two LDL-C responder groups. Seven of the nine genes were discordant between low and high LDL-C responders and therefore were candidates encoding the LDL-C concentration QTL. Notably, Sp1 transcription factor (SP1), apolipoprotein F (APOF), sterol Oacyltransferase 2 (SOAT2) and low-density lipoprotein receptor-related protein 1 (LRP1), implicated in lipoprotein metabolism (20-24), were not differentially expressed in response to the HCHF diet challenge in our study. Our findings suggest we have identified novel candidate genes involved in lipid metabolism-related pathways. Moreover, the identification of multiple related LDL-C trait QTLs overlapping the LDL-C concentration QTL suggests that candidate genes underlying LDL-C concentration may be pleiotropic and play a role in networks related to lipid metabolism.
We further hypothesized that the candidate genes were regulated by miRNAs. miRNAs are small endogenous non-coding RNAs that post-transcriptionally regulate gene expression. Dysregulation of miRNAs has been shown to result in diseases including cancer and atherosclerosis (25,26). Thus, we reasoned that candidate genes targeted by differentially expressed miRNAs in response to the diet challenge might be vital in providing insights on miRNA-related mechanisms influencing dyslipidemia in baboons. Therefore, we prioritized the LDL-C QTL candidate genes by identifying those with miRNA target site in which the miRNAs also exhibit differential response to HCHF diet in low and high LDL-C Although a few genes have previously been associated with LDL-C variation, it is plausible that wellcoordinated signaling pathways regulate dyslipidemia. The four prioritized candidate genes in our study play central roles in AKT1/GSK3β and ACVR/SMAD pathways. These pathways influence key cell biological processes including cell growth and proliferation, cholesterol homeostasis and inflammation.
Further, deregulation of these pathways is associated with complex diseases including various types of cancers (35,36).
For the AKT1/GSK3β pathway, key molecules include three candidate genes (TENC1, ERBB3 and DGKA). The switching of the phosphatidylinositol biphosphate (PIP2) lipid molecule to phosphatidylinositol triphosphate (PIP3) and vice versa through phosphorylation and dephosphorylation, respectively, regulates the pathway. For the high LDL-C responder baboons, DGKA and ERRB3 were up-regulated in response to HCHF diet with no significant change in expression of
TENC1. Previous studies indicate that stimulation of Src tyrosine kinase receptor by growth factors
influences receptor-binding to DGKA, which phosphorylates DG lipid molecule to yield PIP2 (37). To generate AKT1 substrate, PIP3, an ERBB3 receptor, upon stimulation by an epidermal growth factor recruits and forms a heteromeric complex with ERBB2 which possesses intrinsic kinase activity (38).
The complex binds and activates phosphoinositide 3-kinase (PI3K), which phosphorylates and converts
PIP2 to PIP3. PIP3 activates AKT1, which phosphorylates and inactivates GSK3β (39). Inactivated
GSK3β promotes stability and enhances transcription activity of primarily SREBF2 and lipid production (36,40). SREBF2 is a transcription factor that activates expression of genes involved in lipid and cholesterol synthesis (41) . GSK3β inhibits SREBF activity by phosphorylation, triggering targeted ubiquitination and proteosomal degradation (42) . In contrast, TENC1 phosphotase, up-regulated in low LDL-C baboon responders, dephosphorylates PIP3 to PIP2, inhibiting AKT1 activation (43) .
Consequently, the ability of GSK3β to inhibit SREBF transcription activity is enhanced and the result is reduced lipid production and low serum LDL-C levels. The involvement of TENC1 and ERBB3 in the AKT1/GSK3β pathway appears to be agonistic, which is consistent with their discordant expression in low and high LDL-C baboons.
For the ACVR/SMAD pathway, activin is a key stimulator of signal transduction through type I and II activin receptors. ACVR1B (type I receptor) was up-regulated in response to diet challenge in high LDL-C responders whereas there was no significant expression change in low LDL-C animals. Evidence indicates that dietary cholesterol induces hepatic inflammation (44) and our study suggests that the ACVR/SMAD pathway could be involved and modulated by ACVR1B triggering an anti-inflammatory response. ACVR1B lacks active tyrosine kinase domain, thus when bound by activin, the receptor recruits type II activin receptor to activate SMAD2/3 complex which interacts with SMAD 4 to regulate transcription activity of CTNNB1 (β-catennin), a co-activator for TCF/LEP transcription factors that control expression of interleukin cytokines and cell cycle control genes such as CDK activators and inhibitors (45) . Thus, the ACVR/SMAD pathway may influence a plethora of biological processes depending on cell type and context. ACVR1B is a member of the transforming growth factor-beta receptor (TGFR) family of receptors that are master regulators of inflammation, cell proliferation and differentiation (46) . Moreover, both ACVR1B and TGFR are transducers of ACVR/SMAD pathway and are anti-inflammatory, which explains the alleviation of TGFR in atherosclerosis patients (45, 47) .
CONCLUSIONS
Using whole genome expression profiling, QRT-PCR and Western blots for expression profile validation, and integration of miRNA and mRNA expression profiles, we identified four candidate genes encoding an LDL-C concentration QTL on baboon chr 11 that may regulate lipid metabolism via AKT1/GSK3Β and ACVR/SMAD pathways. Discordant expression between low and high LDL animals with inverse expression profiles of miRNAs targeting these candidate genes supports their role in LDL-C metabolism. Of the four candidate genes identified in this study, none are reportedly associated with lipid metabolism, suggesting these are novel genes involved in lipid metabolism-related pathways.
Taken together, our results suggest that the chr 11 QTL for LDL-C concentration is encoded by multiple genes, and that miRNAs regulate these genes. miRNA/mRNA interaction studies are required to validate the network modules. By deciphering the miRNA/mRNA interactions and the mechanisms by which the HCHF diet regulate these miRNAs and mRNAs we will gain new insights into dyslipidemia.
The interconnectedness of the candidate genes underline potential molecular genetic complexities leading to dyslipidemia and atherosclerosis, and suggest that a systems biology approach will be required for disease intervention. 56.8 ▲ ▲ Symbols ▲, ▼, and ▬ indicate up-regulation, down-regulation and no detectable change in gene expression, respectively. 
